Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms.

Chandra J, Hansen M, Labarriere N, Marigo I, Souza-Fonseca-Guimaraes F, Vujanovic L, Koguchi Y, Jacquelot N

Open source

DOI
10.3389/fimmu.2022.939789
Published
2022
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2022.939789,
  title = {Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms.},
  author = {Chandra J and Hansen M and Labarriere N and Marigo I and Souza-Fonseca-Guimaraes F and Vujanovic L and Koguchi Y and Jacquelot N},
  year = {2022},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2022.939789},
  url = {https://doi.org/10.3389/fimmu.2022.939789}
}

RIS

TY  - JOUR
TI  - Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms.
AU  - Chandra J
AU  - Hansen M
AU  - Labarriere N
AU  - Marigo I
AU  - Souza-Fonseca-Guimaraes F
AU  - Vujanovic L
AU  - Koguchi Y
AU  - Jacquelot N
PY  - 2022
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2022.939789
UR  - https://doi.org/10.3389/fimmu.2022.939789
ER  - 

APA

J, C., M, H., N, L., I, M., F, S., L, V., Y, K., & N, J. (2022). Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2022.939789

Source records